Health benefits attributed to 17α-estradiol, a lifespan-extending compound, are mediated through estrogen receptor α.
Health benefits attributed to 17α-estradiol, a lifespan-extending compound, are mediated through estrogen receptor α.
复制标题
归因于17α-雌二醇(一种延伸寿命的化合物)归因于雌激素受体α介导的。
DOI:
10.7554/elife.59616
复制
发表时间:
2020-12-08
期刊:
影响因子:
7.7
通讯作者:
Stout MB
中科院分区:
文献类型:
--
作者:
Mann SN;Hadad N;Nelson Holte M;Rothman AR;Sathiaseelan R;Ali Mondal S;Agbaga MP;Unnikrishnan A;Subramaniam M;Hawse J;Huffman DM;Freeman WM;Stout MB
Metabolic dysfunction underlies several chronic diseases, many of which are exacerbated by obesity. Dietary interventions can reverse metabolic declines and slow aging, although compliance issues remain paramount. 17α-estradiol treatment improves metabolic parameters and slows aging in male mice. The mechanisms by which 17α-estradiol elicits these benefits remain unresolved. Herein, we show that 17α-estradiol elicits similar genomic binding and transcriptional activation through estrogen receptor α (ERα) to that of 17β-estradiol. In addition, we show that the ablation of ERα completely attenuates the beneficial metabolic effects of 17α-E2 in male mice. Our findings suggest that 17α-E2 may act through the liver and hypothalamus to improve metabolic parameters in male mice. Lastly, we also determined that 17α-E2 improves metabolic parameters in male rats, thereby proving that the beneficial effects of 17α-E2 are not limited to mice. Collectively, these studies suggest ERα may be a drug target for mitigating chronic diseases in male mammals.